Cross-condition Validation of the Steroid PRO

Launched by UNIVERSITY OF THE WEST OF ENGLAND · Mar 13, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on studying a special questionnaire designed to understand how patients feel about their treatment with steroids, particularly for conditions affecting the skin, lungs, and stomach. The goal is to gather feedback from patients who have been treated with steroid medications, which are commonly used to reduce inflammation and help manage autoimmune and inflammatory diseases.

To participate in the trial, individuals must be at least 18 years old and have a diagnosed autoimmune or inflammatory condition related to the respiratory system, gastrointestinal system, or skin. They should have received treatment with steroid medications, either through pills or injections, within the past year. Participants will be asked to complete the questionnaire and share their experiences, which could help improve future treatments and patient care. If you or a loved one meet these criteria and are interested, this trial is currently recruiting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥ 18 years old
• • Diagnosed with an autoimmune or inflammatory respiratory, gastroenterology or dermatology condition
• • Treatment with glucocorticoids with intravenous or oral glucocorticoids for an autoimmune or inflammatory condition within the previous year (or longer duration).
• • Ability to give consent.
• Exclusion Criteria:
• • Aged \<18 years old
• • No autoimmune or inflammatory respiratory, gastroenterology or dermatology diagnosis
• • Not treated with glucocorticoids with intravenous or oral glucocorticoids for an autoimmune or inflammatory condition within the previous year (or longer duration)
• • Unable to give consent